<DOC>
	<DOCNO>NCT02955953</DOCNO>
	<brief_summary>The study aim evaluate following : - Whether difference way body handle LY2963016 U-200 LY2963016 U-100 . - How well-tolerated LY2963016 U-200 compare LY2963016 U-100 . - How LY2963016 U-200 affect level blood sugar body compare LY2963016 U-100 . The study last 17 week participant , include initial screening follow .</brief_summary>
	<brief_title>A Study Comparing Two Formulations Insulin Glargine Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Have body mass index ( BMI ) 18.5 29.9 kilogram per meter square ( kg/mÂ² ) Have fast plasma glucose le ( &lt; ) 6.0 millimoles per liter ( mmol/L ) ( 108 milligram per deciliter [ mg/dL ] ) Have venous access sufficient allow blood sample clamp procedure per protocol Have know allergy study drug , component formulation Have donate blood loss 450 milliliter ( mL ) within 3 month prior study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>